About this trial
This study looks at how well people recover after surgery for bone tumors. It focuses on how much function returns after reconstruction with bone grafts or artificial devices. The study will track recovery for three years after surgery, paying attention to how well the bone heals after regenerative surgery.
The trial's ID number is NCT03442465. This is an observational study, which means it looks at how things happen in real life rather than testing a new treatment. It is not regulated by the FDA for drugs or devices. The study aims to include about 300 participants.
Who can join
Anyone aged 4 years and older can join if they are having surgery for bone tumors. This trial is open to both men and women. Participants need to be able to read and understand English. Some people may not be eligible, like those who weigh less than 17 kilograms. The trial team will confirm who can participate.
Conditions
Bone Sarcoma, Osteosarcoma, Chondrosarcoma, Ewing's Sarcoma, Osseous Sarcoma, Bone Neoplasm
The study team makes the final call on eligibility.
What happens in the study
Participants will be placed into two groups based on their type of surgery. One group will have regenerative surgery, and the other will have different types of reconstructive surgery. Everyone will have regular follow-up visits after surgery to assess their recovery. They will take part in various assessments to measure function and healing.
Where
This trial is running at 5 locations in the United States. All of them are currently recruiting.
Memorial Sloan Kettering at Basking Ridge (Consent and Follow Up)
Basking Ridge, New Jersey
Memorial Sloan Kettering at Nassau (Consent and Followup)
Uniondale, New York
Memorial Sloan Kettering Cancer Center
New York, New York
Memorial Sloan Kettering Monmouth (Consent and Followup)
Middletown, New Jersey
Memorial Sloan Kettering Westchester (Consent and Followup)
Harrison, New York